Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Adding PET scans to CT imaging can change treatment for women with cervical cancer

An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging.

17 Sep 2018

Cancer to kill nearly 10 million this year says WHO report

According to a report released by the World Health Organization’s cancer research agency this week, 9.6 million people would lose their lives to cancer this year. This translates as one in eight of all deaths and one in eleven of all deaths among men and women respectively says the agency.

13 Sep 2018

Study provides complete picture of HPV virus-head and neck cancer connections

Human papillomavirus is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils.

12 Sep 2018

New method of cervical cancer screening eliminates Pap test

The United States Preventive Services Task Force has released new recommendations on screening for cervical cancer.

22 Aug 2018

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.

22 Aug 2018

Screening for HPV could replace routine Pap smears

According to health advisors from the U.S. Preventive Services Task Force, Pap smears may not be the only way to check for cervical cancer risk among women.

22 Aug 2018

Comprehensive analysis informs new recommendation for national cervical cancer screening

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

21 Aug 2018

Infection rates of high risk oral HPV in England found to be lower than expected

Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

20 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Powerful new microscope reveals inner workings of human cells with unprecedented clarity

Australia’s most advanced and powerful microscope, capable of visualizing down to the level of individual atoms, begins its working life today.

14 Aug 2018

Removing the cancer label - overhaul in cancer classification proposed

Australian researchers have asked for changes in the way doctors tend to label low risk cancerous conditions as “cancer” leading to over treatment. Certain diagnoses such as localised prostate cancer or “stage 0” breast cancers need to be looked at say the researchers at the University of Sydney and Bond University to prevent aggressive treatment where it is not needed.

12 Aug 2018

UC Davis expert explains about surge in HPV-related throat cancer

Humanpapilloma virus is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

1 Aug 2018

Researchers describe strategy used by Oropouche virus to replicate in human cells

The strategy used by the Oropouche virus to replicate in human cells has been described for the first time by researchers at the University of São Paulo in Brazil and international collaborators in an article published in the journal PLOS Pathogens.

31 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Cancer and heart disease are deadlier in the developing world than in western nations

Diseases such as cancer, heart disease and stroke are deadlier in the developing world than in rich nations. This is the finding of a new analysis from researchers at Imperial College London.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

New control system regulates morphology, orientation of cells constituting animal tissues

A collaborative research group led by Kumamoto University has developed a new control system for regulating the morphology and orientation of cells that constitute animal tissues.

25 Jul 2018

HPV vaccines for boys in UK

The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.

25 Jul 2018

Insurance gains improve outcome for young women with gynecologic cancers

The gains in insurance coverage with the Patient Protection and Affordable Care Act (ACA) have already translated into improved health for young women with gynecologic cancers, who are getting diagnosed at earlier stages of their disease because of ACA benefits.

12 Jul 2018

HPV test better than Pap when screening for cervical cancer

The Pap smear test has been used widely for the past five decades to understand and screen for early signs of cervical cancer. The conventional test has been largely replaced by a liquid-based Pap cytology test. Soon it may be replaced by another test – the Human papilloma virus test or the HPV test finds new research.

4 Jul 2018

Cervical Cancer News and Research

Further Reading

Adding PET scans to CT imaging can change treatment for women with cervical cancer

Cancer to kill nearly 10 million this year says WHO report

Study provides complete picture of HPV virus-head and neck cancer connections

New method of cervical cancer screening eliminates Pap test

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Screening for HPV could replace routine Pap smears

Comprehensive analysis informs new recommendation for national cervical cancer screening

Infection rates of high risk oral HPV in England found to be lower than expected

Discovery may help broaden the scope of defenses against HPV

Powerful new microscope reveals inner workings of human cells with unprecedented clarity

Removing the cancer label - overhaul in cancer classification proposed

UC Davis expert explains about surge in HPV-related throat cancer

Researchers describe strategy used by Oropouche virus to replicate in human cells

CNDA approves KEYTRUDA for treatment of advanced melanoma

Cancer and heart disease are deadlier in the developing world than in western nations

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

New control system regulates morphology, orientation of cells constituting animal tissues

HPV vaccines for boys in UK

Insurance gains improve outcome for young women with gynecologic cancers

HPV test better than Pap when screening for cervical cancer

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News